Use of the Seer Cancer Registry for Technology Assessment
- 1 January 1991
- journal article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 7 (2) , 134-142
- https://doi.org/10.1017/s026646230000502x
Abstract
The Surveillance, Epidemiology, and End Results (SEER) cancer registry contributed to technology assessment by providing population-based samples for detailed case-control studies, by serving as the control group in comparisons with various experimental groups, by allowing an assessment of selection bias in clinical trials, and by facilitating evaluations of classification and coding systems.Keywords
This publication has 1 reference indexed in Scilit:
- Second Cancers in Patients With Chronic Lymphocytic Leukemia2JNCI Journal of the National Cancer Institute, 1987